The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
The primary aim of 'MasterBayes' is to use Markov chain Monte Carlo (MCMC) techniques to integrate over uncertainty in pedigree configurations estimated from molecular markers and phenotypic data (Hadfield et al. (2006) <doi:10.1111/j.1365-294X.2006.03050.x>). Emphasis is put on the marginal distribution of parameters that relate the phenotypic data to the pedigree. All simulation is done in compiled 'C++' for efficiency.
| Version: | 2.59 |
| Depends: | coda, genetics, gtools, kinship2 |
| Imports: | methods, stats |
| Published: | 2026-03-19 |
| DOI: | 10.32614/CRAN.package.MasterBayes |
| Author: | Jarrod Hadfield [aut, cre], Andrew D. Martin [ctb, cph] (Original author of modified C++ Scythe code), Kevin M. Quinn [ctb, cph] (Original author of modified C++ Scythe code), Daniel Pemstein [ctb, cph] (Original author of modified C++ Scythe code) |
| Maintainer: | Jarrod Hadfield <j.hadfield at ed.ac.uk> |
| License: | GPL-2 | GPL-3 [expanded from: GPL (≥ 2)] |
| NeedsCompilation: | yes |
| Citation: | MasterBayes citation info |
| CRAN checks: | MasterBayes results |
| Reference manual: | MasterBayes.html , MasterBayes.pdf |
| Vignettes: |
MasterBayes Tutorial (source) |
| Package source: | MasterBayes_2.59.tar.gz |
| Windows binaries: | r-devel: MasterBayes_2.59.zip, r-release: MasterBayes_2.59.zip, r-oldrel: MasterBayes_2.59.zip |
| macOS binaries: | r-release (arm64): MasterBayes_2.59.tgz, r-oldrel (arm64): MasterBayes_2.59.tgz, r-release (x86_64): MasterBayes_2.59.tgz, r-oldrel (x86_64): MasterBayes_2.59.tgz |
| Old sources: | MasterBayes archive |
Please use the canonical form https://CRAN.R-project.org/package=MasterBayes to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.